221 related articles for article (PubMed ID: 21862932)
1. Cerebrospinal fluid tenascin-C in cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Suzuki H; Kanamaru K; Shiba M; Fujimoto M; Imanaka-Yoshida K; Yoshida T; Taki W
J Neurosurg Anesthesiol; 2011 Oct; 23(4):310-7. PubMed ID: 21862932
[TBL] [Abstract][Full Text] [Related]
2. Tenascin-C is a possible mediator between initial brain injury and vasospasm-related and -unrelated delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Suzuki H; Kanamaru K; Shiba M; Fujimoto M; Kawakita F; Imanaka-Yoshida K; Yoshida T; Taki W
Acta Neurochir Suppl; 2015; 120():117-21. PubMed ID: 25366610
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of lipid peroxides as predictive of symptomatic vasospasm and poor outcome after aneurysmal subarachnoid hemorrhage.
Kamezaki T; Yanaka K; Nagase S; Fujita K; Kato N; Nose T
J Neurosurg; 2002 Dec; 97(6):1302-5. PubMed ID: 12507127
[TBL] [Abstract][Full Text] [Related]
4. The postoperative C-reactive protein level can be a useful prognostic factor for poor outcome and symptomatic vasospasm in patients with aneurysmal subarachnoid hemorrhage.
Jeon YT; Lee JH; Lee H; Lee HK; Hwang JW; Lim YJ; Park HP
J Neurosurg Anesthesiol; 2012 Oct; 24(4):317-24. PubMed ID: 22732721
[TBL] [Abstract][Full Text] [Related]
5. A non-enzymatic derived arachidonyl peroxide, 8-iso-prostaglandin F2 alpha, in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage participates in the pathogenesis of delayed cerebral vasospasm.
Asaeda M; Sakamoto M; Kurosaki M; Tabuchi S; Kamitani H; Yokota M; Watanabe T
Neurosci Lett; 2005 Jan; 373(3):222-5. PubMed ID: 15619547
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 levels in plasma and cerebrospinal fluid of patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Kessler IM; Pacheco YG; Lozzi SP; de Araújo AS; Onishi FJ; de Mello PA
Surg Neurol; 2005; 64 Suppl 1():S1:2-5; discussion S1:5. PubMed ID: 15967223
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage.
Moritz S; Warnat J; Bele S; Graf BM; Woertgen C
J Neurosurg Anesthesiol; 2010 Jan; 22(1):21-31. PubMed ID: 20027011
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide metabolites in cisternal CSF correlate with cerebral vasospasm in patients with a subarachnoid haemorrhage.
Woszczyk A; Deinsberger W; Böker DK
Acta Neurochir (Wien); 2003 Apr; 145(4):257-63; discussion 263-4. PubMed ID: 12748885
[TBL] [Abstract][Full Text] [Related]
9. S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage.
Sanchez-Peña P; Pereira AR; Sourour NA; Biondi A; Lejean L; Colonne C; Boch AL; Al Hawari M; Abdennour L; Puybasset L
Crit Care Med; 2008 Aug; 36(8):2267-73. PubMed ID: 18596638
[TBL] [Abstract][Full Text] [Related]
10. [Symptomatic vasospasm after subarachnoid hemorrhage: study of 186 cases].
Liu WG; Yang XF; Cao F; Zheng XJ; Shen H; Fu WM; Lü ST
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(15):1040-3. PubMed ID: 16784707
[TBL] [Abstract][Full Text] [Related]
11. Analysis of intrathecal interleukin-6 as a potential predictive factor for vasospasm in subarachnoid hemorrhage.
Schoch B; Regel JP; Wichert M; Gasser T; Volbracht L; Stolke D
Neurosurgery; 2007 May; 60(5):828-36; discussion 828-36. PubMed ID: 17460517
[TBL] [Abstract][Full Text] [Related]
12. Serum and cerebrospinal fluid C-reactive protein levels as predictors of vasospasm in aneurysmal subarachnoid hemorrhage. Clinical article.
Fountas KN; Tasiou A; Kapsalaki EZ; Paterakis KN; Grigorian AA; Lee GP; Robinson JS
Neurosurg Focus; 2009 May; 26(5):E22. PubMed ID: 19409001
[TBL] [Abstract][Full Text] [Related]
13. The impact of microsurgical fenestration of the lamina terminalis on shunt-dependent hydrocephalus and vasospasm after aneurysmal subarachnoid hemorrhage.
Komotar RJ; Hahn DK; Kim GH; Khandji J; Mocco J; Mayer SA; Connolly ES
Neurosurgery; 2008 Jan; 62(1):123-32; discussion 132-4. PubMed ID: 18300899
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y - an early biomarker for cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Schebesch KM; Brawanski A; Bele S; Schödel P; Herbst A; Bründl E; Kagerbauer SM; Martin J; Lohmeier A; Stoerr EM; Proescholdt M
Neurol Res; 2013 Dec; 35(10):1038-43. PubMed ID: 23915659
[TBL] [Abstract][Full Text] [Related]
15. Association of an endogenous inhibitor of nitric oxide synthase with cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
Jung CS; Oldfield EH; Harvey-White J; Espey MG; Zimmermann M; Seifert V; Pluta RM
J Neurosurg; 2007 Nov; 107(5):945-50. PubMed ID: 17977265
[TBL] [Abstract][Full Text] [Related]
16. Increased Plasma Galectin-3 Preceding the Development of Delayed Cerebral Infarction and Eventual Poor Outcome in Non-Severe Aneurysmal Subarachnoid Hemorrhage.
Nishikawa H; Nakatsuka Y; Shiba M; Kawakita F; Fujimoto M; Suzuki H;
Transl Stroke Res; 2018 Apr; 9(2):110-119. PubMed ID: 28831694
[TBL] [Abstract][Full Text] [Related]
17. Admission angiographic cerebral circulation time may predict subsequent angiographic vasospasm after aneurysmal subarachnoid hemorrhage.
Udoetuk JD; Stiefel MF; Hurst RW; Weigele JB; LeRoux PD
Neurosurgery; 2007 Dec; 61(6):1152-9; discussion 1159-61. PubMed ID: 18162893
[TBL] [Abstract][Full Text] [Related]
18. Metabolites from cerebrospinal fluid in aneurysmal subarachnoid haemorrhage correlate with vasospasm and clinical outcome: a pattern-recognition 1H NMR study.
Dunne VG; Bhattachayya S; Besser M; Rae C; Griffin JL
NMR Biomed; 2005 Feb; 18(1):24-33. PubMed ID: 15455468
[TBL] [Abstract][Full Text] [Related]
19. Proteomic biomarker discovery in cerebrospinal fluid for cerebral vasospasm following subarachnoid hemorrhage.
Lad SP; Hegen H; Gupta G; Deisenhammer F; Steinberg GK
J Stroke Cerebrovasc Dis; 2012 Jan; 21(1):30-41. PubMed ID: 20851633
[TBL] [Abstract][Full Text] [Related]
20. Imatinib mesylate prevents cerebral vasospasm after subarachnoid hemorrhage via inhibiting tenascin-C expression in rats.
Shiba M; Suzuki H; Fujimoto M; Shimojo N; Imanaka-Yoshida K; Yoshida T; Kanamaru K; Matsushima S; Taki W
Neurobiol Dis; 2012 Apr; 46(1):172-9. PubMed ID: 22300707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
